HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sudhir Rawal Selected Research

Castration

9/2023Enzalutamide-Induced Acute Maculopapular Rash in Treatment of Metastatic Prostate Cancer: First Case Report from a Tertiary Cancer Care Center of North India.
12/2021A Narrative Review of Implementing Precision Oncology in Metastatic Castration-Resistant Prostate Cancer in Emerging Countries.
10/2020Correction to: Safety Profile and Therapeutic Efficacy of One Cycle of Lu177-PSMA in End-Stage Metastatic Castration-Resistant Prostate Cancer Patients with Low Performance Status.
9/2020A Walk with Lu-177 PSMA: How Close we Have Reached from Bench to Bedside?
9/2020Is 177Lu-PSMA an effective treatment modality for mCRPC patients with bone and visceral metastasis?
1/2020Activation of GPR56, a novel adhesion GPCR, is necessary for nuclear androgen receptor signaling in prostate cells.
12/2019Safety Profile and Therapeutic Efficacy of One Cycle of Lu177-PSMA in End-Stage Metastatic Castration-Resistant Prostate Cancer Patients with Low Performance Status.
4/2019Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sudhir Rawal Research Topics

Disease

17Prostatic Neoplasms (Prostate Cancer)
09/2023 - 07/2015
14Neoplasms (Cancer)
10/2023 - 01/2013
6Margins of Excision
04/2024 - 10/2018
6Neoplasm Metastasis (Metastasis)
03/2022 - 01/2018
5Ischemia
10/2023 - 12/2020
5Carcinoma (Carcinomatosis)
06/2018 - 01/2008
4Intraoperative Complications
11/2022 - 10/2018
4Urinary Bladder Neoplasms (Bladder Cancer)
07/2021 - 09/2008
3Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2022 - 04/2009
2Adenocarcinoma
09/2023 - 12/2018
2Necrosis
01/2023 - 01/2018
2Testicular Neoplasms (Testicular Cancer)
04/2020 - 10/2017
2Lymphadenopathy
01/2018 - 12/2016
1Endometrial Neoplasms (Endometrial Cancer)
12/2023
1Morbid Obesity
10/2023
1Exanthema (Rash)
09/2023
1Wounds and Injuries (Trauma)
01/2023
1Vulvar Neoplasms (Vulvar Cancer)
01/2023
1Infections
01/2023
1Injection Site Reaction
03/2022
1Cardiovascular Diseases (Cardiovascular Disease)
03/2022
1Cysts
10/2021
1COVID-19
05/2021
1Renal Cell Carcinoma (Grawitz Tumor)
04/2020
1Pain (Aches)
12/2019
1Body Weight (Weight, Body)
04/2018
1Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
04/2018
1Edema (Dropsy)
01/2018
1Lymphatic Metastasis
07/2017
1Sarcoma (Soft Tissue Sarcoma)
01/2017
1Carcinosarcoma
01/2017
1Ovarian Neoplasms (Ovarian Cancer)
12/2016
1Adnexal Diseases
12/2016
1Vaginal Neoplasms (Cancer, Vaginal)
01/2016
1Prostatic Intraepithelial Neoplasia
07/2015
1Sepsis (Septicemia)
04/2012

Drug/Important Bio-Agent (IBA)

8AntigensIBA
01/2021 - 07/2017
3gallium 68 PSMA-11IBA
01/2021 - 07/2017
3AndrogensIBA
04/2020 - 01/2013
2CreatinineIBA
10/2023 - 09/2022
2Androgen Receptors (Androgen Receptor)IBA
01/2020 - 07/2015
2GalliumIBA
04/2019 - 12/2018
2Prostate-Specific Antigen (Semenogelase)IBA
04/2018 - 07/2015
1Hemoglobins (Hemoglobin)IBA
10/2023
1enzalutamideIBA
09/2023
1acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamideFDA Link
03/2022
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
03/2022
1Goserelin (Zoladex)FDA Link
03/2022
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021
1MART-1 AntigenIBA
10/2021
12- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
07/2021
1Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
05/2021
1FurinIBA
05/2021
1Gallium-68IBA
01/2021
1P-2 (P 2)IBA
12/2020
1Lutetium-177IBA
09/2020
1LigandsIBA
01/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020
1LutetiumIBA
12/2019
1Peptide Receptors (Peptide Receptor)IBA
04/2019
1Irpex lacteus aspartic proteinase (ILAP)IBA
12/2016
1Oncogene Proteins (Oncogene Protein)IBA
01/2013
1Formaldehyde (Formol)FDA Link
01/2013
1ParaffinIBA
01/2013

Therapy/Procedure

8Castration
09/2023 - 04/2019
7Nephrectomy
10/2023 - 10/2018
5Operative Time
04/2024 - 09/2008
5Therapeutics
09/2020 - 01/2016
4Warm Ischemia
04/2024 - 10/2018
4Lymph Node Excision (Lymph Node Dissection)
01/2023 - 01/2017
4Cystectomy
10/2018 - 01/2008
3Neoadjuvant Therapy
12/2023 - 04/2009
3Length of Stay
10/2023 - 01/2018
3Blood Transfusion (Blood Transfusions)
10/2023 - 12/2021
2Hysterectomy
08/2022 - 01/2016
2Prostatectomy (Retropubic Prostatectomy)
07/2017 - 01/2013
2Urinary Diversion (Ileal Conduit)
04/2012 - 09/2008
1Adjuvant Chemotherapy
12/2023
1Pelvic Exenteration
12/2021
1Salvage Therapy
12/2021
1Palliative Care (Palliative Therapy)
09/2020
1Orchiectomy (Orchidectomy)
04/2020
1Radiotherapy
04/2019
1Stents
04/2012
1Laparotomy
09/2008